Publication

ANNÉE

2017

AUTEURS

Bascoul-Mollevi C, Gourgou S, Galais MP, Raoul JL, Bouché O, Douillard JY, Adenis A, Etienne PL, Juzyna B, Bedenne L, Conroy T

CONGRÈS/REVUE

Eur J Cancer

Etude

PRODIGE 5-UNICANCER-ACCORD17/0707

Localisation

Cancer de l’Œsophage et de l’Estomac

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ejca.2017.07.038

Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial

ANNÉE

2017

AUTEURS

Lambert A, Jarlier M, Gourgou Bourgade S, Conroy T

CONGRÈS/REVUE

PLoS One

Etude

PRODIGE 4-UNICANCER-ACCORD11/0402

Localisation

Cancer du Pancréas

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1371/journal.pone.0183288

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours

ANNÉE

2017

AUTEURS

Lepage C, Dahan L, Bouarioua N, Toumpanakis C, Legoux JL, Le Malicot K, Guimbaud R, Smith D, Tougeron D, Lievre A, Cadiot G, Di Fiore F, Bouhier-Leporrier K, Hentic O, Faroux R, Pavel M, Borbath I, Valle JW, Rinke A, Scoazec JY, Ducreux M, Walter T

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 31-FFCD-1301 REMINET

Localisation

Néoplasie Neuroendocrine

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2017.02.004

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

ANNÉE

2017

AUTEURS

Azria D, Doyen J, Jarlier M, Martel-Lafay I, Hennequin C, Etienne P, Vendrely V, Francois E, de La Roche G, Bouche O, Mirabel X, Denis B, Mineur L, Berdah J, Mahe M, Becouarn Y, Dupuis O, Lledo G, Seitz J, Bedenne L, Gourgou-Bourgade S, Juzyna B, Conroy T, Gerard J

CONGRÈS/REVUE

Ann Oncol

Etude

PRODIGE 2-UNICANCER-ACCORD12/0405

Localisation

Cancer du Rectum et du Canal

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1093/annonc/mdx351

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

ANNÉE

2017

AUTEURS

Pernot S, Badoual C, Terme M, Castan F, Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Bachet JB, Borg C, Ducreux M, Marcheteau E, Stanbury T, Gourgou S, Malka D, Taieb J

CONGRÈS/REVUE

Eur J Cancer

Etude

PRODIGE 17-UNICANCER-ACCORD200904/0904 MEGA

Localisation

Cancer de l’Œsophage et de l’Estomac

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ejca.2017.03.036

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

ANNÉE

2017

AUTEURS

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

CONGRÈS/REVUE

Eur J Cancer

Etude

PRODIGE 1-FFCD-PETACC8

Localisation

Cancer du Côlon non métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ejca.2017.04.025

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

ANNÉE

2016

AUTEURS

Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C

CONGRÈS/REVUE

JAMA

Etude

PRODIGE 8-GERCOR-LAP07

Localisation

Cancer du Pancréas

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1001/jama.2016.4324

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

ANNÉE

2016

AUTEURS

Vernerey D, Huguet F, Vienot A, Goldstein D, Paget-Bailly S, Van Laethem JL, Glimelius B, Artru P, Moore MJ, André T, Mineur L, Chibaudel B, Benetkiewicz M, Louvet C, Hammel P, Bonnetain F

CONGRÈS/REVUE

Br J Cancer

Etude

PRODIGE 8-GERCOR-LAP07

Localisation

Cancer du Pancréas

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1038/bjc.2016.212

Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial

ANNÉE

2016

AUTEURS

Barbieri A, Anota A, Conroy T, Gourgou-Bourgade S, Juzyna B, Bonnetain F, Lavergne C, Bascoul-Mollevi C

CONGRÈS/REVUE

Med Decis Making

Etude

PRODIGE 4-UNICANCER-ACCORD11/0402

Localisation

Cancer du Pancréas

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1177/0272989X15621883

PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial

ANNÉE

2016

AUTEURS

Aparicio T, Francois E, Cristol-Dalstein L, Carola E, Maillard E, Paillaud E, Retornaz F, Faroux R, Andre T, Bedenne L, Seitz JF

CONGRÈS/REVUE

Dig Liver Dis

Etude

PRODIGE 34-FFCD-1402 ADAGE

Localisation

Cancer Colorectal Métastatique

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2015.11.023